DESIGN, OPTIMIZATION AND IN-VITRO EVALUATION OF GASTRORETENTIVE HOLLOW MICROSPHERES OF FAMOTIDINE
*Ragini Shukla and Nitin Dwivedi
Peoples Institute of Pharmacy and Research Centre, Bhopal (M.P.) India
ABSTRACT
Hollow microspheres (Microballoons) floatable in USP XXI (SGFpH1.2)
solution were developed as a dosage form characterized by
excellent buoyant properties in the stomach. Microballons were
prepared by the novel emulsion solvent diffusion method utilizing
enteric acrylic polymers codissolved with drug in a mixture of
dichloromethane and ethanol. The drug polymer compatibility was
determined by FTIR studies. For optimization of prepared
microspheres effects of varying polymer ratio concentration, drug
concentration, surfactant concentration, and stirring speed on particle
size and drug loading were studied. Optimized formulation was then
characterized for particle size, scanning electron microscopy (SEM),
drug entrapment and buoyancy percentage. The results obtained were
found in desired ranges where the drug entrapment efficiency of
microspheres was found to be ranging from 65.17±1.4% to
178.2±2.5%, size of microspheres found in the range 81.2±2.9 to 90.2±3.4 μm. The shape of
the microspheres was found to be spherical by SEM. The microspheres on floatation along
with surfactant, floated continuously for more than 8 hrs. in SGF (pH-1.2). The percentage
cumulative amount of drug release was found to 91.2±% in SGF (PH 1.2) after 24 hrs. The
results clearly suggest that prepared hollow microsphere formulation of famotidine may
prove to be a potential candidate for prolonged drug release in stomach, thereby improving
the bioavailability and patient compliance.
Keywords: Microballoons, Famotidine, Eudragit-S 100, floating controlled drug delivery system.
[Download Article]
[Download Certifiate]